Figure 4 | Scientific Reports

Figure 4

From: Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)

Figure 4

Efficacy study in Balb/c nude mice bearing A549 subcutaneous tumors. Cetuximab + 558 showed significantly improved tumor growth inhibition over Cetuximab alone (P < 0.001 for Cetuximab + 558 v/s Cetuximab alone, two-way ANOVA with multiple comparisons). Statistical significance is based on comparisons from the last day of the study.

Back to article page